These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 18426820)

  • 1. Evaluation of health-related quality of life in patients with Cushing's syndrome with a new questionnaire.
    Webb SM; Badia X; Barahona MJ; Colao A; Strasburger CJ; Tabarin A; van Aken MO; Pivonello R; Stalla G; Lamberts SW; Glusman JE
    Eur J Endocrinol; 2008 May; 158(5):623-30. PubMed ID: 18426820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using subscales when scoring the Cushing's quality of life questionnaire.
    Tiemensma J; Depaoli S; Felt JM
    Eur J Endocrinol; 2016 Jan; 174(1):33-40. PubMed ID: 26431845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychometric performance of the CushingQoL questionnaire in conditions of real clinical practice.
    Santos A; Resmini E; Martínez-Momblán MA; Crespo I; Valassi E; Roset M; Badia X; Webb SM
    Eur J Endocrinol; 2012 Sep; 167(3):337-42. PubMed ID: 22677433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychometric evaluation of the Cushing's Quality-of-Life questionnaire.
    Nelson LM; Forsythe A; McLeod L; Pulgar S; Maldonado M; Coles T; Zhang Y; Webb SM; Badia X
    Patient; 2013; 6(2):113-24. PubMed ID: 23575965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Worse Health-Related Quality of Life at long-term follow-up in patients with Cushing's disease than patients with cortisol producing adenoma. Data from the ERCUSYN.
    Valassi E; Feelders R; Maiter D; Chanson P; Yaneva M; Reincke M; Krsek M; Tóth M; Webb SM; Santos A; Paiva I; Komerdus I; Droste M; Tabarin A; Strasburger CJ; Franz H; Trainer PJ; Newell-Price J; Wass JA; Papakokkinou E; Ragnarsson O;
    Clin Endocrinol (Oxf); 2018 Jun; 88(6):787-798. PubMed ID: 29574994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of the Tuebingen CD-25 Inventory as a Measure of Postoperative Health-Related Quality of Life in Patients Treated for Cushing's Disease.
    Milian M; Kreitschmann-Andermahr I; Siegel S; Kleist B; Führer-Sakel D; Honegger J; Buchfelder M; Psaras T
    Neuroendocrinology; 2015; 102(1-2):60-7. PubMed ID: 25968090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired quality of life in patients in long-term remission of Cushing's syndrome of both adrenal and pituitary origin: a remaining effect of long-standing hypercortisolism?
    Wagenmakers MA; Netea-Maier RT; Prins JB; Dekkers T; den Heijer M; Hermus AR
    Eur J Endocrinol; 2012 Nov; 167(5):687-95. PubMed ID: 22936421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health-related quality of life of patients with hypothalamic-pituitary-adrenal axis dysregulations: a cohort study.
    De Bucy C; Guignat L; Niati T; Bertherat J; Coste J
    Eur J Endocrinol; 2017 Jul; 177(1):1-8. PubMed ID: 28404594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Negative illness perceptions are associated with impaired quality of life in patients after long-term remission of Cushing's syndrome.
    Tiemensma J; Kaptein AA; Pereira AM; Smit JW; Romijn JA; Biermasz NR
    Eur J Endocrinol; 2011 Oct; 165(4):527-35. PubMed ID: 21798958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of the disease-specific QOL-CD quality of life questionnaire for patients with Cushing's disease.
    Cusimano MD; Huang TQ; Marchie A; Smyth HS; Kovacs K
    Neurosurg Focus; 2020 Jun; 48(6):E4. PubMed ID: 32480368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of quality of life in 102 patients with treated Cushing's disease.
    Carluccio A; Sundaram NK; Chablani S; Amrock LG; Lambert JK; Post KD; Geer EB
    Clin Endocrinol (Oxf); 2015 Mar; 82(3):404-11. PubMed ID: 24931777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mapping CushingQoL scores onto SF-6D utility values in patients with Cushing's syndrome.
    Roset M; Badia X; Forsythe A; Webb SM
    Patient; 2013; 6(2):103-11. PubMed ID: 23549927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment effectiveness of pasireotide on health-related quality of life in patients with Cushing's disease.
    Webb SM; Ware JE; Forsythe A; Yang M; Badia X; Nelson LM; Signorovitch JE; McLeod L; Maldonado M; Zgliczynski W; de Block C; Portocarrero-Ortiz L; Gadelha M
    Eur J Endocrinol; 2014 Jul; 171(1):89-98. PubMed ID: 24760537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drawings reflect a new dimension of the psychological impact of long-term remission of Cushing's syndrome.
    Tiemensma J; Daskalakis NP; van der Veen EM; Ramondt S; Richardson SK; Broadbent E; Romijn JA; Pereira AM; Biermasz NR; Kaptein AA
    J Clin Endocrinol Metab; 2012 Sep; 97(9):3123-31. PubMed ID: 22723334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease-specific quality of life evaluation and its determinants in Cushing's syndrome: what have we learnt?
    Badia X; Valassi E; Roset M; Webb SM
    Pituitary; 2014 Apr; 17(2):187-95. PubMed ID: 23564339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A specific nursing educational program in patients with Cushing's syndrome.
    Martínez-Momblán MA; Gómez C; Santos A; Porta N; Esteve J; Úbeda I; Halperin I; Campillo B; Guillaumet M; Webb SM; Resmini E
    Endocrine; 2016 Jul; 53(1):199-209. PubMed ID: 26400845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mapping CushingQOL scores to EQ-5D utility values using data from the European Registry on Cushing's syndrome (ERCUSYN).
    Badia X; Roset M; Valassi E; Franz H; Forsythe A; Webb SM
    Qual Life Res; 2013 Dec; 22(10):2941-50. PubMed ID: 23539468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Affective alterations in patients with Cushing's syndrome in remission are associated with decreased BDNF and cortisone levels.
    Valassi E; Crespo I; Keevil BG; Aulinas A; Urgell E; Santos A; Trainer PJ; Webb SM
    Eur J Endocrinol; 2017 Feb; 176(2):221-231. PubMed ID: 27932530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of life in Cushing's syndrome.
    Santos A; Crespo I; Aulinas A; Resmini E; Valassi E; Webb SM
    Pituitary; 2015 Apr; 18(2):195-200. PubMed ID: 25647329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ARE THERE RELIABLE PREDICTORS FOR THE IMPAIRED QUALITY OF LIFE IN PATIENTS WITH CUSHING'S SYNDROME?
    Nankova AB; Yaneva M; Elenkova A; Kalinov K; Zacharieva S
    Acta Endocrinol (Buchar); 2019; 15(4):482-490. PubMed ID: 32377246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.